Related Experiment Video
Updated: Nov 4, 2025
05:17
Author Spotlight: Enhancing the Offspring Health in Rats with Maternal Exercise During Pregnancy
Published on: April 5, 2024
1.0K
Prescribing for pregnancy: managing diabetes.
Alice Hurrell1, Sara L White1, Louise Mary Webster2
1Women and Children's Health, King's College London, London, UK.
Drug and Therapeutics Bulletin
|May 26, 2021
Summary
Drug and Therapeutics Bulletin (DTB) review articles offer concise summaries of treatments for optimal patient care. These articles provide key points and patient overviews, often with continuing medical education (CME) questions.
Area of Science:
- Medical Information
- Pharmacology
- Patient Care
Background:
- Drug and Therapeutics Bulletin (DTB) provides evidence-based drug information.
- Editorial board selects topics for review articles to ensure relevance and clinical utility.
Purpose of the Study:
- To offer concise overviews of medicines and treatments.
- To support healthcare professionals in providing optimal patient care.
- To enhance medical knowledge through accessible summaries.
Main Methods:
- Selection of review topics by the DTB editorial board.
- Development of articles summarizing key points and patient information.
- Inclusion of multiple-choice continuing medical education (CME) questions.
Main Results:
- DTB articles provide clear, concise summaries of therapeutic options.
- Patient-friendly overviews are included to improve understanding.
- CME questions facilitate knowledge assessment and professional development.
Conclusions:
- DTB review articles are a valuable resource for clinicians seeking up-to-date treatment information.
- The format supports both professional learning and patient education.
- DTB aims to improve the quality of patient care through accessible drug information.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
3.7K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.7K
01:20Pathophysiology of Diabetes
2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.3K
01:15Diabetes: Management and Pharmacotherapy
661
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
661
01:15Hypoglycemia and Glucagon
498
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
498
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
383
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
383
01:16Insulin: Dosing Regimen and Adverse Effects
355
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
355